Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b84637b8f369dca84b59d02dfd4db2d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01b2a2533c97b47d2036e05c9f04cdb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11024 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
filingDate |
2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb99818d0f0a02702411d3ac7aa5baf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e12f07e55db0e210e1c2041333e97775 |
publicationDate |
2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005214755-A1 |
titleOfInvention |
Map kinase integrin-binding domain |
abstract |
Dislosed is the integrin-binding domain of MAP kinase. Interaction between MAP kinase and integrin via this domain activates MAP kinase and initiates cellular activity. Methods of modulating cellular activity by inhibiting direct MAP kinase-integrin binding are provided. These methods have particular use in inhibiting growth of cancer cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014073028-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006390-B2 |
priorityDate |
2000-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |